Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations
Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations have?
Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations has 19 citations in the OpenAlex counts ScholarIQ stores.
When was Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations published?
Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations has 2018 year in the ScholarIQ index.
What is the open-access status of Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations?
Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations has closed oa status in the ScholarIQ index.
What is the DOI of Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations?
The DOI for Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations is on the source record.
What is the PMID of Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations?
The PMID for Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations is on the source record.
What is the OpenAlex record for Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations?
The OpenAlex for Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations is on the source record.